EMD-14887

Single-particle
4.0 Å
EMD-14887
3D View Gallery
Deposition: 03/05/2022
Map released: 01/06/2022
Last modified: 20/11/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links

EMD-14887
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 7zr9 summary report (pdf.gz) Map and 7zr9 FULL report (pdf.gz)
EMICSS annotations (xml)

OMI-2 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN

EMD-14887

Single-particle
4.0 Å
EMD-14887
3D View Gallery
Deposition: 03/05/2022
Map released: 01/06/2022
Last modified: 20/11/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Sample Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2, Enterobacteria phage T4
Sample: OMI-2 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN
Fitted models: 7zr9

Deposition Authors: Duyvesteyn HME, Ren J, Stuart DI
Potent cross-reactive antibodies following Omicron breakthrough in vaccinees.
Nutalai R , Zhou D , Tuekprakhon A , Ginn HM, Supasa P, Liu C, Huo J, Mentzer AJ, Duyvesteyn HME, Dijokaite-Guraliuc A , Skelly D , Ritter TG , Amini A , Bibi S, Adele S, Johnson SA, Constantinides B, Webster H, Temperton N , Klenerman P, Barnes E , Dunachie SJ , Crook D, Pollard AJ, Lambe T, Goulder P, Paterson NG, Williams MA , Hall DR, Mongkolsapaya J , Fry EE, Dejnirattisai W, Ren J, Stuart DI , Screaton GR
(2022) Cell , 185 , 2116 - 2131.e18
PUBMED: 35662412
DOI: doi:10.1016/j.cell.2022.05.014
ISSN: 1097-4172